LENZ vs UDR · rev $7.4M vs P/E 26, rev $1.71B
LENZ Therapeutics Inc (LENZ) versus UDR Inc (UDR) — a side-by-side from cached financials, not a winner call.
LENZ Therapeutics Inc (LENZ) is a biotechnology company listed on US.
UDR Inc (UDR) is a reit - residential company listed on NYSE.
Latest reported LENZ revenue for 2026-06-30 was $7.4M. Net income was -$73.4M. LENZ currently screens at market cap $223.6M.
Latest reported UDR revenue for 2025-12-31 was $1.71B. Net income was $377.7M. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
LENZ currently screens at market cap $223.6M. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
Not investment advice. Open the LENZ and UDR stock pages for the full models.
Not investment advice.